UBS raises M&T Bank target to $252
UBS analyst Erika Najarian maintained a Neutral rating on M&T Bank and raised the price target to $252 from $225. This follows similar target increases by Evercore, JP Morgan, Baird, Wells Fargo, and Morgan Stanley.

*this image is generated using AI for illustrative purposes only.
UBS analyst Erika Najarian maintained a Neutral rating on M&T Bank and raised the price target to $252 from $225. This adjustment adds to a series of recent valuation updates for the financial institution. Evercore ISI Group analyst John Pancari maintained an In-Line rating and raised the price target to $260 from $225. JP Morgan analyst Andrew Dietrich previously maintained a Neutral rating and raised the price target to $251.5 from $227. Baird analyst David George downgraded the stock from Outperform to Neutral with a price target of $240. Wells Fargo analyst Mike Mayo maintained an Underweight rating and raised the price target to $215 from $205. M&T Bank shares closed at $238.88 on Thursday.
The divergent analyst views highlight shifting valuations for M&T Bank. Wells Fargo's Underweight stance suggests the stock is expected to underperform relative to the broader market sector, while Baird's move to Neutral indicates an expectation of in-line performance. JP Morgan's Neutral rating aligns with a view of balanced risk and reward at the new price level. Evercore's In-Line rating similarly suggests performance consistent with the market.
| Firm | Rating | Price Target |
|---|---|---|
| Wells Fargo | Underweight | $215 |
| Baird | Neutral | $240 |
| UBS | Neutral | $252 |
| JP Morgan | Neutral | $251.5 |
| Morgan Stanley | Equal-Weight | $253 |
| Evercore ISI Group | In-Line | $260 |
Morgan Stanley analyst Manan Gosalia previously maintained an Equal-Weight rating and raised the price target to $253 from $245. M&T Bank trades on the NYSE under the ticker MTB.
What factors are driving the divergence in analyst ratings for M&T Bank?
How might M&T Bank's recent performance influence future analyst adjustments?
What potential market conditions could lead to further price target revisions?



























